Pulsenmore Stock
Pulsenmore Ltd. Ordinary Shares
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- Israel
- CEO
- Elazar Sonnenschein
- Employees
- 71
- Market cap
- $12 M
- IPO
- 21/01/2026
Pulsenmore Ltd. specializes in delivering self-scanning ultrasound technology for distant medical diagnosis and health screening throughout Israel and Europe. Its primary offering is the Pulsenmore at-home ultrasound system, which consists of a portable ultrasound unit that attaches to a patient's smartphone. An…
Pulsenmore stock: price history
1D
+3.3%
1W
+1.1%
1M
-22.4%
6M
-48.8%
YTD
–
1Y
–
2Y
–
5Y
–
10Y
–
Ask the agents about Pulsenmore
Pulsenmore stock metrics
P/E
-0.82
P/B
0.77
EV/EBITDA
-1.02
RETURN ON EQUITY
-75.7%
NET MARGIN
-576.8%
DEBT/EQUITY
0.71
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
59.4%
FLOAT SHARES
3,859,748
AVG. DAILY VOLUME (30D)
80,768
Insider transactions (SEC)
Guz-Lavi Racheli
Comparable stocks
Frequently asked questions about Pulsenmore stock
What does Pulsenmore do?
Pulsenmore Ltd. Ordinary Shares is a company in the Healthcare sector, Medical - Devices industry, headquartered in Israel.
The CEO is Elazar Sonnenschein, the company employs around 71 people.
The IPO was on 21/01/2026; the stock trades on NASDAQ under the ticker PLSM.
Does Pulsenmore pay a dividend?
No, Pulsenmore currently does not pay a dividend.
Which stocks are comparable to Pulsenmore?
Comparable stocks include Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Siemens Healthineers, DexCom and GE HealthCare Technologies.
How can I get Pulsenmore stock analyzed?
Clicking "Analyze stock" lets five strategies assess Pulsenmore against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.